Channing Capital Management’s Dorman Products DORM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$78.2M Sell
637,520
-27,799
-4% -$3.68M 2.05% 18
2026
Q2
$90.8M Buy
+665,319
New +$78.8M 2.09% 20
2022
Q3
– Sell
-1,880
Closed -$206K – 108
2022
Q2
$206K Buy
+1,880
New +$186K 0.01% 107
2022
Q1
– Sell
-1,880
Closed -$212K – 107
2021
Q4
$212K Buy
+1,880
New +$204K 0.01% 106
2021
Q2
– Sell
-2,067
Closed -$212K – 114
2021
Q1
$212K Buy
+2,067
New +$206K 0.01% 107
2020
Q1
– Sell
-203,052
Closed -$15.4M – 112
2019
Q4
$15.4M Sell
203,052
-254,701
-56% -$19.3M 0.71% 46
2019
Q3
$36.4M Buy
457,753
+44,962
+11% +$3.49M 1.68% 31
2019
Q2
$36M Sell
412,791
-19,844
-5% -$1.72M 1.67% 29
2019
Q1
$38.1M Buy
432,635
+166,396
+62% +$14.5M 1.76% 28
2018
Q4
$24M Buy
+266,239
New +$21.3M 1.2% 36

Other funds holding DORM

Channing Capital Management's DORM Position: Q3 2026 in Review

Channing Capital Management reduced its Dorman Products (DORM) stake by 4.2% in Q3 2026, selling an estimated $3.68M and leaving 637,520 shares worth $78.2M. The position accounts for 2.05% of the portfolio, ranked #18.

Channing Capital Management first reported a position in DORM in Q4 2018 and has held it in 10 quarters since. The position peaked at $90.8M in Q2 2026. 135 funds tracked by Wall St. Rank hold DORM as of Q3 2026.

  • Channing Capital Management held 637,520 shares of Dorman Products worth $78.2M as of Q3 2026.
  • Channing Capital Management sold 27,799 Dorman Products shares in Q3 2026, an estimated $3.68M.
  • Dorman Products made up 2.05% of Channing Capital Management's portfolio in Q3 2026, its #18 holding.
  • Channing Capital Management first reported a position in Dorman Products in Q4 2018 and has held it in 10 quarters since.
  • Channing Capital Management's Dorman Products position peaked at $90.8M in Q2 2026.
  • 135 funds tracked by Wall St. Rank held Dorman Products as of Q3 2026.

Based on Channing Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.